Press Releases

Irish Company Develops Cloud-Based App Aimed to Accelerate Global COVID-19 Vaccination Process

BOC Sciences Provides Extensive Catalog of Building Blocks

MICROSENSDX RapiPRO™ LAMP for SARS-CoV-2 RECEIVES CE MARK APPROVAL

MedAI Integrates Its Drug Research and Development Platform for the Pharmaceutical Industry

Thermo Fisher Scientific Collaborates with Artificial to Enhance COVID-19 Diagnostic Testing Solution

Thermo Fisher Scientific, which today announced their collaboration with Artificial to increase the productivity of COVID-19 testing through an integrated and comprehensive software automation platform.

Ceryx Medical appoints Chas Taylor as Chairman

Ceryx Medical, the business behind a revolutionary technology that could significantly change the way patients with serious heart problems are treated, has appointed Chas Taylor, a leading medical devices entrepreneur, as Chairman.

Creative BioMart Biomarker Released Multiple Biomarker Detection Service

Lifeasible Updated Its Animal Metabolomics Analysis Service

Continuous manufacturing μLOT® enabling technology could cut pharma industry’s use of toxic chemicals by one hundred times

Speaking at the ‘Innovative Chemistry for Peptide Manufacturing and Analysis’ conference, SB3000’s Chief R&D Officer Jens Bukrinski revealed that continuous manufacturing μLOT® technology could reduce the pharmaceutical industry’s use of toxic chemicals by 100 times.

Formulationbio Newly Launches Disintegrant Excipients for Pharmaceutical Preparation

SignalChem Enters a Clinical Trial Collaboration with Merck to Evaluate the Effect of SLC-391 in Combination with KEYTRUDA® (pembrolizumab) in Advanced Non-Small Cell Lung Cancer

SignalChem Lifesciences, a clinical-stage company developing novel targeted therapies for oncology, has announced a collaboration with Merck, through a subsidiary, to evaluate the combination of SLC-391, a selective AXL inhibitor developed by SignalChem, with KEYTRUDA®, Merck’s anti-PD-1 therapy, in patients with advanced non-small cell lung cancer (NSCLC).

RegDesk Launches ‘Dash 2.0’ to Improve Medical Device Applications

RegDesk, a regulatory approval software company, has released an updated version of its 'Dash' platform for device manufacturers.

Matexcel Offers a Comprehensive List of Graphene Products

Creative Biostructure Provides Various Vaccine Development Services for Coronavirus

Profacgen Provides Immunogenicity Testing Services to Help with Drug Discovery and Development

Albumedix announces recombinant human albumin supply partnership with FUJIFILM Wako Pure Chemical Corporation for the Japanese, Chinese and Hong Kong markets

Albumedix Ltd., an enabler of advanced therapies and world leader in recombinant human albumin, has announced a new distribution partnership with FUJIFILM Wako Pure Chemical Corporation (FUJIFILM Wako), to advance therapy and biopharmaceutical development in Japan and China including Hong Kong.

Alfa Chemistry Catalysts Launches Catalysts for Olefin Metathesis Reaction

ENPICOM and Viroclinics-DDL receive joint MIT Zuid subsidy to accelerate and improve antibody and vaccine discovery and development

ENPICOM BV, an innovative bioinformatics software engineering company, has announced the approval of a joint MIT Zuid subsidy (SME Innovation Stimulation Top Sectors South Holland) application with Viroclinics-DDL, a state-of-the-art Contract Research Organization specialized in molecular diagnostic testing and assay development.

Panthera is running a Ph 3 trial for AstraZeneca’s monoclonal antibody combination to reduce the effects of COVID-19 in patients with the virus from its North Manchester site

Panthera is enrolling Covid patients for AstraZeneca’s monoclonal antibody study to reduce disease severity.

EXTENSIVE OFFERING OF CLINICAL REFERENCE MATERIALS FOR BILIRUBIN TESTING NOW AVAILABLE FROM VERICHEM LABORATORIES

VERICHEM LABORATORIES now offers medical laboratory professionals an extensive array of liquid stable, protein based, ready-to-use clinical reference material for Total and Direct Bilirubin assays for CLIA compliance.